reinstat coverag neutral rate target price follow restrict
wait lead program firm initi coverag neutral rate target price
dmd child left behind initi coverag outperform rate target price
stuff cheap stock deservingli less reiter outperform rais estim target price
updat debt-to-capit dac charg lower estim
 much larger compani revis estim rais target price
previous disclos result maintain estim
closer look hood affirm compani bullish lt messag ramp still st focu
zijin come top nsu
thing mondelez could creat valu
convers compani leader suggest cautiou optim dmd program
guidanc secur flexibl fund
note takeaway dinner rl ceo cfo
denial river egypt
na august truck order order moon
kick nfl season trend tracker
lead la vega latest view lead indic
speak economi
make open remark boston
chang nonfarm payrol aug
chang privat payrol aug
energi confer dalla
analyst disclosur credit suiss seek busi compani cover research
report result investor awar firm may conflict interest could affect
object report investor consid report singl factor make invest
reinstat coverag neutral rate traget price follow restrict
reinstat coverag tp neutral rate follow research restrict target price base
weight navp use multipl opcfa use
invest view rate kgc neutral though retain construct bia due compani above-averag leverag
gold price would need see sustain gold price recoveri becom posit kgc current
price dynam expect compani look preserv cash hold back growth capital-expenditure tasiast expans
cs commod price deck remain unchang continu assum
long-term silver beyond
model updat catch model actual result updat capital-expenditure cost tax close align
guidanc model gold product cost sale aisc capital-expenditure
assum explor cost vs guidanc cost vs
guidanc opex vs guidanc dd a/oz vs guidanc tax expens
vs guidanc expect tax recoveri fulli off-set tax expens
estim ep increas updat actual updat assumpt
commod price oper key risk view
wait lead program firm initi coverag neutral rate target price
like demonstr initi efficaci dmd gene therapi clear mechanist rational
well support preclin proof-of-concept base model assum gene therapi becom standard care dmd
sustain run rate revenu anticip clinic differenti time market durabl
among meaning arbit valu among three clinical-stag dmd gene therapi product
expect long-term data refin think model assumpt
differenti matter see low likelihood clear efficaci differenti earli clinic
gene therapi updat assum function level dystrophin express three clinic player in-lin
preclin profil think competit initi profil efficaci may support nt upsid
improv po data expect howev longer term see potenti risk share price solid
third mover fail produc differenti clinic data experi delay owe regulatori issu
steadi newsflow dmd gene therapi come month expect updat result
gene therapi program later year top-lin result program note
clinic success view posit share far rel valuat argument
think bar could elev profil matur initi data produc dystrophin express
initi neutral target price valuat dcf-driven po dmd gene therapi
market share risk thesi includ clinic regulatori commerci headwind
receiv product pleas specifi credit suiss contact email call
dmd child left behind initi coverag outperform rate target price
comprehens dmd platform led gene therapi despit high expect dmd gene therapi program
see room continu share appreci program develop expect initi data three clinic
stage gene therapi program like demonstr robust dystrophin express skelet muscl think
mover advantag strong initi data set high bar strong competit posit long-term point clinic
differenti may emerg exampl suggest construct may produc greater dystrophin express
heart think preclin evid capsids/promot use could provid support hypothesi
substanti dmd may yield one gene therapi blockbust model market share
peak sale approach annual recur revenu run-rat long-term
steadi newsflow pipelin anticip addit dmd gene therapi data octob
expect initi clinic data lgmd gene therapi program annual
revenu opportun deliv initi muscl biopsi data earli also expect regulatori file pmo
address exon skip complement commerci exon skip exondi franchis
dmd come month earli safety/dos escal next-gen ppmo program dmd earli
successor commerci pmo product exondi togeth believ pmo/ppmo offer
support valuat floor absenc gene therapi
initi outperform target price valuat base sotp dcf dmd gene therapi
key compon risk includ clinic regulatori commerci headwind
stuff cheap stock deservingli less reiter outperform rais estim target price
cs view olli report anoth strong quarter continu benefit heighten closeout deal flow
reflect comp versu consensu cse suppli chain pressur freight pressur gross
margin posit merchandis margin indic buy prowess sg control yield ep
vs cse expect anticip benefit toy us bankruptci top mind call
clearli posit toy lap difficult comparison year driven fidget
spinner eas post best stack comp quarter mention first comp guid
half-year memori valuat remain elev see near amazon-proof model deserv premium
peer rais target price reiter outperform rate
detail quarter post compstore two-year stack basi
depart comp posit notabl bp improv oper margin versu estim
bp primarili driven tight expens control pace leverag sg strong comp bp
benefit less anticip tax reform-rel invest rais comp guidanc
fy sale billion billion reflect opportun toy categori
ep
estim tp rais fy ep estim fy estim
updat target price assum trade ntm earn estim month
approxim current trade ntm price-to-earnings risk rate target price includ revers
top-lin trend chang closeout buy environ
receiv product pleas specifi credit suiss contact email call
updat debt-to-capit dac charg lower estim
overview sept provid three updat tender offer four class debt prefer share
issuanc price sept increas dac charg base annual actuari assumpt review
target debt reduct offer premium everi princip select tender
secur debt due debt due debt due senior note due
earli tender deadlin pm sept offici tender expir pm oct debt
secur combin carri valu
prefer issuanc off-set debt reduct improv capit price prefer share sept
offer price yield proce expens like decreas adjust debt-to-
capit due partial equiti treatment prefer share current debt-to-capit target
estim net impact transact ep neutral
estim guid dac unlock charg reduc ep possibl prompt
divest individu life unit unfavor experi legaci block life insur led expect increas
reinsur cost and/or busi recaptur although issu discuss far back earn call
think neg updat may acceler interest exit individu life segment lower
ep estim result guidanc dac charg
reiter outperform rate target price potenti upsid despit anticip neg dac updat
like effort improv capit posit think highli attract capital-light busi san individu life
risk price target includ spread compress sensit equiti market potenti advers loss ratio
experi employe benefit busi
 much larger compani revis estim rais target price
reiter outperform rate rais tp follow blow-out calcul bill y/i vs
street oper also impress vs consensu perform strong
everi measur underscor compani uniqu leadership posit futur security-in cloud stock
trade afterhour amidst heighten expect zs vs igv sinc jul non-fundament forc ipo
lock-up expir sep seemingli rich valuat respect factor real believ
rare strateg gem need valu context real growth strateg potenti
competit besid valuat competit pushback hear investor similar
sound messag like symc maintain zs uniqu much way salesforc com
disrupt incumb leader siebel system mani year ago sever data point reinforc
includ multipl custom success stori increasingli larger scale
valuat context histori suggest success grow high-teen revenu multipl near imposs
exist preced regardless believ zs strateg asset fundament justifi
tp use ev/rev/growth multiple-in line saa peers-bas revenu compound-annual-growth-rate
impli bill waterfal note upward revis bill estim would impli even greater upsid
right indic billings-to-revenu waterfal may seem aggress note impli upsid
base case revenu vs out-performance street estim past quarter sinc ipo similarli
think growth look reason context lead indic like annual bill estim
current backlog exit year
estim rev/bil estim increas risk includ slowdown
receiv product pleas specifi credit suiss contact email call
miss miss estim tie continu chassi avail issu impact
longer materi lead time drive product ineffici issu delay product shipment three segment
importantli continu drag result sale increas y/i
consensu estim adjust ebitda consensu estim adjust
ep street estim segment sale fell adjust
ebitda margin bp last year tie chassi suppli chain issu result lower
ambul shipment time fire truck shipment vs last year commerci sale improv
impact well chassi avail issu bu divis adjust ebitda margin
last year declin reflect mix well under-perform specialti product line recreat sale increas
adjust ebitda margin y/i help acquisit larg backlog
y/i help acquisit larg flat sequenti bought back stock still
persist lack execut issu weigh name
guid lower lower guidanc given poor perform quarter
driven suppli chain constraint particularli chassi lengthen materi lead time under-perform rel
target class rv specialti product part chassi materi issu expect persist
revenu expect vs previou guid street adjust
ebitda seen vs previou guid street impli adjust
ebitda vs street adjust ebitda margin impli ramp adjust net incom
seen vs previou guid street
previous disclos result maintain estim
cushman alreadi pre-announc result littl way surpris quarter cushman
report adjust ebitda million line compani pre-announc level ahead august ipo
adjust ep total also line estim
fee revenu mix total fee revenu mix servic line line expect previous
announc term geograph mix america revenu better expect emea apac
lower estim
net debt pro-forma ipo pay lien loan net debt second quarter
million higher estim
maintain estim maintain ebitda adjust ep estim follow quarter
reiter outperform surpris result reinforc confid abil drive
ebitda growth revenu growth margin expans
closer look hood affirm compani bullish lt messag ramp still st focu
assembl line product effort on-going ramp domin convers annual
investor day expect use year event seattl highlight multitud effici drive
busi across model thorough tour product line span
two major boe facil everett renton produc widebodi narrowbodi respect two
tour lengthi visit leadership across compani detail insid place signific
emphasi autom flexibl assembl line
mani egg basket boe good job showcas bullish outlook long term remain
mind compani optim around product recoveri ramp investor analyst press
manag throughout day issu behind recent delay explain situat
improv reiter follow deliveri littl light compani expect fulli catch
delay materi impact result one fli ointment
reconcil glider park facil assert execut recoveri plan
cfm engin also somewhat fault dearth certain specialti metal compon fuselag remain long
pole tent see key risk ba target
howev invest thesi take somewhat longer view remain enthusiast overal macro
micro stori potenti quarterli fine-tun forecast remain intact reiter
outperform rate tp risk includ slowdown commerci oe cycl execut risk
receiv product pleas specifi credit suiss contact email call
zijin come top nsu
nevsun resourc receiv offer septemb zijin mine group nevsun resourc
announc zijin agre acquir nsu total deal valu cash offer subject
nevsun sharehold approv highlight nevsun board director support offer zijin offer repres
signific premium lundin latest public announc hostil bid
signific premium nsu share view zijin offer approxim higher lundin revis offer
made juli lundin origin offer joint eurosun approxim cash share
offer note mildli accret lun lundin revis offer cash would
slightli better despit cash offer slightli accret acquisit given lundin strong
balanc sheet vs peer howev zijin offer signific premium lun latest offer sharehold
support would like neg lun balanc sheet strength need copper growth asset would
enough off-set premium view
lun unlik top zijin offer although scarciti copper develop acquisit project may entic lundin increas
offer believ lun unlik proceed revis offer given current price tag
timok everyon realli want oct nevsun announc updat pea timok upper zone
copper project technic report file dec indic after-tax project discount rate
flat copper highlight includ year lom produc copper pre-product
capit mine locat serbia nevsun state md permit stage pea aim start
product
thing mondelez could creat valu
report dive five thing think manag could focu improv growth rate
stock price next three year hope see new ceo dirk van de put touch topic lay
compani new strateg plan compani investor day septemb leadership posit
advantag snack categori sale come fast-grow develop market believ stock
price-to-earnings multipl rerat least higher closer nestl unilev colgat organ growth rate re-
acceler
introduc organ growth target high single-digit ep growth target begin
invest less north american distribut press competit advantag versu
increas support tail brand fulli leverag north america high fix cost natur new manufactur line
futur
de-centr commerci team increas account make local market perform bigger part
divest non-cor chees groceri busi use proce buy back stock acquir contemporari
health-ori snack brand consid monet coffe equiti hold purpos
valuat target price conserv impli multipl forward ep estim reflect
premium us peer food group essenti in-lin histor averag premium volatil
condit emerg market potenti execut problem north america pose largest threat target
receiv product pleas specifi credit suiss contact email call
convers compani leader suggest cautiou optim dmd program
cautious optimist dmd gene therapi program seen increas interest investor effort
gene therapi specif program duchenn muscular dystrophi dmd opportun
speak two leader area michael bink vice-president diseas clinic research robert smith
head global gene therapi busi discuss program base preclin studi
conduct date appear excit cautious optimist progress made program
current phase manag point program develop year research multipl
chang made transgen compani made multipl adapt optim current
construct use phase studi expect year data twelv patient would comment
potenti data releas prior
encourag rat mdx studi believ better approach model cardiac express point exact
clinic differenti among key player sarepta solid remain unclear howev thought leader point
cardiac improv potenti differenti point believ dmd construct good chanc
demonstr cardiac impact base new preclin rat mdx model use compani note
mous mdx model perform reason well less aggress heart rat mdx model better reflect
cardiac diseas seen dmd believ may also conduct studi mous mdx model well
larger anim canin disclos data sarepta argu construct greater dystrophin
express heart dystrophin express heart vs skelet muscl use mous mdx model
could potenti differenti pleas see initi report marti auster team
detail dmd
guidanc secur flexibl fund
bottom line dropdown secur nep announc plan acquir mw wind mw solar project
us parent neer includ cash remaind tax equiti non-recours debt
dropdown expect close project cafd better prior estim cafd acquisit
requir meet run-rate guidanc dropdown fund proce canada asset sale close
importantli via convert equiti portfolio financ structur result lower debt servic cost
next three year view transact support distribut growth rate tp
accret return dropdown impli cash yield line compani guidanc prior deal calcul
project irr high singl digit accret lp investor even potenti dilut repay event four
flexibl convert equiti financ option convert equiti fund behav like
coupon debt next three year howev fourth year nep either pay back effect rate
return form nep equiti price market ii allow ownership structur flip
receiv project cafd result lower irr nep still respect vs compet financ option
result mid high singl digit irr first option eas futur equiti issuanc like use
latter provid flexibl market conduc
model adjust dp estim unchang higher end compani guidanc growth y/i increas
cafd estim due lower expect debt
servic new convert equiti risk estim includ rise interest rate capit market liquid asset
receiv product pleas specifi credit suiss contact email call
note takeaway dinner rl ceo cfo
confid build around rl revenu lead indic rl alreadi give solid margin target mid-teen
 share repo plan june analyst day stock becom show stori around rev inflect
posit year declin revenue growth rl core america wholesal market held back
off-price/bont/distribut exit think market underappreci key lead indic
inflect lower markdowns/high aur aur msd year lap hsd last year rl continu
significantli reduc markdown estim off-pric help drive on-going pricing/margin
opportun full price even sever year strong aur increas improv sell-out trend think
fall/holiday core men busi key lead indic brand plan flat rl get
confid could turn posit yoy first time sever yr base retail order sell-out trend better
channel inventori level retail margin turn posit inflect posit dec-qtr remain posit
support on-going sell-out improvements/inventori management rl remain top pick
still room major sourc investor pushback late corpor peak
think core na wholesal still sever hundr bp recent peak despit significantli lower off-
price/markdown markdown allow retail bigger gm driver still higher level today
allow typic lag sell-thru said sell-thru improv sequenti rl reduc inventori
allow make progress sever seasons-which auger well gm upsid
valuat target price base ebitda
denial river egypt
confus investor competitor on-going confer investor ask think
note quick encapsul key point feel free reach team addit detail
garden leav note pressur pump price permian soften consider said soften
held consider said see other talk one said
custom chang plan want say yet of compani alway last know
right overal activ permian like slow sinc gear grow product
need maintain anoth quarter activ product growth resum
downcycl everyon treat
guy work compani addit oil take-away capac might notic
downturn work small privat privat equiti back compani take-away capac left might either
add increment rig lay one depend work industri whole slow
guy
wall street rig count probabl declin much super spec rig turn back
chanc get anoth one quarter reduc super spec rig us market
rig pressur pump spread alreadi go idl marcellu permian duc count build
lead edg spot rate price earlier year note consider soften
also price lower end rang put idl equip work say walk away match bid like
might say custom built compani support right
wall street everi spread work price adjust next four quarter
anoth spend back-end weight creat anoth leg upward momentum
alreadi strong base current busi visibl industri seen year understand
concern of price activ next quarter quiet confid seen industri manag
basi investor realiz next year aggress buyer
expect market begin discount recoveri later year
receiv product pleas specifi credit suiss contact email call
na august truck order order moon
heavi duti order roof august class preliminari order came unit vs expect
high-thirti order sequenti juli order y/i rel last year
season adjust basi class order unit repres third best month histori
nomin season adjust basi year-to-d august class monthli order averag
unit like substanti order report june juli prompt larger fleet place order ahead
normal season cadenc typic around octob believ strength order reflect concern
avail given constraint oe supplier level previous indic broader environ truck
industri remain strong carrier post record profit margin backlog record level believ oe
like go materi price increas price/cost headwind look septemb
expect around unit although like surpris upsid
medium duti order strong medium duti order came unit august class
class repres increas m/m y/i
kick nfl season trend tracker
nfl viewership fare season pre-season start built databas nfl
viewership data track rate trend close season includ analysi show overal pre-season view
year y/i pre-season perform alway correl regular season result
certainli suggest possibl continu nfl view declin
trend tracker nfl content remain import program tv media compani advertis result
neg impact declin nfl viewership season thought mani
easi comparison election-impact season mind expect nfl view
track close season media investor eye toward predict ad result gaug
overal pace tv deterior end offer weekli nfl rate last season timeslot comparison
year result becom avail well analysi annual nfl rate trend today give
context shift view take place
earli season match-up found new thursday footbal packag get strong start
begin week nbc snf also start strong espn mnf match-up appear weaker y/i cb
lead la vega latest view lead indic
lead la vega weekli updat lead indic la vega strip macro dashboard
latest view news flow la vega recent initi coverag game industri slide deck replay
initi confer call avail id
new pushback price airlin capac cruel summer investig
pushback price resort fee sourc recent controversi outlin initi
risen meaning sinc lv local report sever la vega execut aggress push big
reduct resort fee park fee resort fee flow entir adr revpar remain
seen wind-back resort fee would reflect higher base room rate
airlin capac growth remain good forward air capac vega track y/i remaind
year slightli ahead ytd growth decemb capac releas septemb novemb
cruel summer y/i drop convent attend juli y/i decreas total visit
outlier versu ytd trend -and like support view weak reflect combin tough comp
aggress price shadow suppli growth unfavor event calendar price-sensit leisur custom
rather wholesal deterior condit strip forward convent calendar present note
estim convent attend flat y/i
regulatori investig due month-end massachusett expect present investig
public hear mid-to-l septemb nevada expect conclud investig late septemb
view consensu expect receiv fine face materi sanction
fun fact lego releas la vega architectur skylin set piec featur bellagio encor
stratospher freemont street vital vega
receiv product pleas specifi credit suiss contact email call
headlin price previou day close unless otherwis note
compani mention price sep
